High resolution ultrasound imaging for repeated measure of wound tissue morphometry, biomechanics and hemodynamics under fetal, adult and diabetic conditions

Non-invasive, repeated interrogation of the same wound is necessary to understand the tissue repair continuum. In this work, we sought to test the significance of non-invasive high-frequency high-resolution ultrasound technology for such interrogation. High-frequency high-resolution ultrasound imaging was employed to investigate wound healing under fetal and adult conditions. Quantitative tissue cellularity and elastic strain was obtained for visualization of unresolved inflammation using Vevo strain software. Hemodynamic properties of the blood flow in the artery supplying the wound-site were studied using color Doppler flow imaging. Non-invasive monitoring of fetal and adult wound healing provided unprecedented biomechanical and functional insight. Fetal wounds showed highly accelerated closure with transient perturbation of wound tissue cellularity. Fetal hemodynamics was unique in that sharp fall in arterial pulse pressure (APP) which was rapidly restored within 48h post-wounding. In adults, APP transiently increased post-wounding before returning to the pre-wounding levels by d10 post-wounding. The pattern of change in the elasticity of wound-edge tissue of diabetics was strikingly different. Severe strain acquired during the early inflammatory phase persisted with a slower recovery of elasticity compared to that of the non-diabetic group. Wound bed of adult diabetic mice (db/db) showed persistent hypercellularity compared to littermate controls (db/+) indicative of prolonged inflammation. Normal skin strain of db/+ and db/db were asynchronous. In db/db, severe strain acquired during the early inflammatory phase persisted with a slower recovery of elasticity compared to that of non-diabetics. This study showcases a versatile clinically relevant imaging platform suitable for real-time analyses of functional wound healing.

Companies, COVID-19 and Respect for Human Rights

The relentless spread of Coronavirus Disease 2019 (COVID-19)1 has been exponential, with an alarming number of deaths2 putting health systems under severe strain. The World Health Organization (WHO) has declared COVID-19 a pandemic3 and health experts cannot predict when a vaccine may be available, or when the spread will slow.

Expert Update for Doctors on COVID-19: A Summary of the Event

In light of the rapid developments of the coronavirus disease 2019 (COVID-19) epidemic in China, a panel of experts came together on 12th February at the Royal College of Physicians in London, UK. The experts discussed current data on COVID-19 and the measures being taken by Public Health England (PHE). According to Prof Jimmy Whitworth, from the London School of Hygiene and Tropical Medicine (LSHTM), in London, UK, COVID-19 is clinically very similar to a severe flu to which the population has no immunity and for which a vaccine is not available. Therefore, a severe strain could be put on health services if this became a UK epidemic. This could have wider implications on daily life such as transport, food supplies, and mass gatherings.

Morocco-Turkey trade agreement is under serious strain

Headline MOROCCO/TURKEY: Trade agreement is under severe strain

Spatiotemporal Spread of Cacao Swollen Shoot Virus Severe Strain 1A in Mixed Hybrid Cacao Pre-inoculated With Mild Strain N1

The spatiotemporal spread of cocoa swollen shoot virus disease (CSSVD), which is caused by cacao swollen shoot virus (CSSV) severe strain 1A in mixed hybrid cacao pre-inoculated with CSSV mild strain N1 (CSSV-N1), was investigated during a field experiment from 2006 to 2017, at the Cocoa Research Institute of Ghana. The development of disease epidemics has been described by the use of statistical modeling. Protecting all cacao plants with CSSV-N1 reduced the rate of CSSV-1A symptom appearance by 43% (P = 0.05) compared with the nonprotected control and by 33% compared with plots where cacao plants in the outer three or five rows were protected with CSSV-N1. Similarly, creating the protective outer rings three or five rows deep reduced the rate of CSSV-1A symptoms by 14% (P = 0.05) compared with the nonprotected control. CSSV-1A epidemics increased approximately 18% faster (P = 0.05) in transects oriented from the north and east compared with those oriented from the south and west. During the last 2 years of the study, CSSVD spread decreased significantly (P = 0.05) faster in plots where all test cacao plants were inoculated with CSSV-N1 compared with other treatments. The growth of cacao did not differ significantly among the treatments over the 9-year assessment period. Similarly, differences in the cumulative yield among the treatments over the 8-year assessment period were not significant.

A New Era for Mild Strain Cross-Protection

Societal and environmental pressures demand high-quality and resilient cropping plants and plant-based foods grown with the use of low or no synthetic chemical inputs. Mild strain cross-protection (MSCP), the pre-immunization of a plant using a mild strain of a virus to protect against subsequent infection by a severe strain of the virus, fits with future-proofing of production systems. New examples of MSCP use have occurred recently. New technologies are converging to support the discovery and mechanism(s) of action of MSCP strains thereby accelerating the popularity of their use.